Multiple Sclerosis Clinical Trials in New York, New York

13 studies are recruiting for multiple sclerosis in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

   This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York

   Locations

   52 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT03816345 on ClinicalTrials.gov

2. A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

   The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting

   Stage

   Not phased

   Ages

   18 and older

   Site

   TG Therapeutics Investigational Trial Site, New York, New York

   Locations

   109 in total

   Run by

   TG Therapeutics, Inc.

   See if you can join NCT06433752 on ClinicalTrials.gov

3. An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

   This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with Multiple Sclerosis.

   Stage

   Phase 1

   Ages

   18 to 60

   Site

   Research Site, New York, New York

   Locations

   19 in total

   Run by

   AstraZeneca

   See if you can join NCT07224373 on ClinicalTrials.gov

4. A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

   This study will have two Phases: Phase 1a and Phase 1b. The goals of this clinical study are to learn more about the study drug KITE-363, by evaluating its safety, tolerability and efficacy in participants with relapsed/refractory autoimmune neurologic diseases. The primary objectives of this study…

   Stage

   Phase 1

   Ages

   18 to 75

   Site

   Columbia University Irving Medical Center, New York, New York

   Locations

   8 in total

   Run by

   Kite, A Gilead Company

   See if you can join NCT07304154 on ClinicalTrials.gov

5. Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

   The goal of this clinical trial is to evaluate if the study drug will reduce brain and retinal atrophy by reducing inflammation and subsequently slowing neurodegeneration in people with Multiple Sclerosis. The main outcome for the trial is change in normalized brain parenchymal volume (nBPV), measu…

   Stage

   Phase 2

   Ages

   18 to 60

   Site

   Mount Sinai School of Medicine, New York, New York

   Locations

   2 in total

   Run by

   Johns Hopkins University

   See if you can join NCT07497399 on ClinicalTrials.gov

6. Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)

   This project is a double-blind, sham-controlled, parallel-arm, randomized controlled trial. We will recruit n=170 people living with MS, who are experiencing an episode of depression in the context of a major depressive episode (MDE). Using our remotely supervised (RS) tDCS protocol, enrolled parti…

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   NYU Langone Health, New York, New York

   Run by

   NYU Langone Health

   See if you can join NCT06901687 on ClinicalTrials.gov

7. Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders

   In this protocol, a combination of MRI, blood, and cerebrospinal fluid (CSF) analysis will be used to understand the natural history, underlying immunologic mechanisms, and clinical implications of central nervous system (CNS) lesions, in particular lesions in the cerebral cortex, in multiple scler…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Mount Sinai Hospital, New York, New York

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT05982925 on ClinicalTrials.gov

8. Genes and Environment in Multiple Sclerosis

   The purpose of the research study is to identify the genetic, environmental and immune profiles that may increase a person's risk of developing multiple sclerosis (MS). While MS is not a disease caused by a single variation in genetic material (DNA), a single environmental factor, or a single malfu…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Columbia University Irving Center, New York, New York

   Locations

   5 in total

   Run by

   Columbia University

   See if you can join NCT01353547 on ClinicalTrials.gov

9. A Study of the MIND Diet for Persons With Multiple Sclerosis

   This study will assess the impact of a MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) diet on brain health and MS symptoms. Participants will be randomly assigned to one of two arms: the diet intervention arm or the "continue current diet"/control arm. Participants randomized to…

   Stage

   Not phased

   Ages

   18 to 70

   Site

   Mount Sinai Hospital, New York, New York

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT06992115 on ClinicalTrials.gov

10. Vancomycin Study in Multiple Sclerosis (MS)

    The overall goal of this study is to elucidate a mechanism by which vancomycin modulates the gut-brain axis in multiple sclerosis (MS). The gut microbiome plays an important role in autoimmunity, including MS. However, the identity of gut microbes modulating neuroinflammation in MS and their mechan…

    Stage

    Phase 1

    Ages

    18 to 50

    Site

    Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York, New York

    Run by

    Icahn School of Medicine at Mount Sinai

    See if you can join NCT05539729 on ClinicalTrials.gov

11. NYSCF Scientific Discovery Biobank

    The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store th…

    Stage

    Not phased

    Ages

    0 and older

    Site

    New York Stem Cell Foundation Research Institute, New York, New York

    Run by

    New York Stem Cell Foundation Research Institute

    See if you can join NCT06203106 on ClinicalTrials.gov

12. Eccentric Exercise and Fatigue in Multiple Sclerosis

    The goal of this observational study is to compare the impact of eccentric resistance training to traditional resistance training on fatigue in persons with multiple sclerosis (MS). The primary question this study is asking is the following: is eccentric resistance training more fatiguing than trad…

    Stage

    Not phased

    Ages

    18 to 75

    Site

    Hunter College, Physical Therapy Department, City University of New York, New York, New York

    Run by

    Hunter College of City University of New York

    See if you can join NCT06505421 on ClinicalTrials.gov

13. Effect of Cooling on Balance Performance in Multiple Sclerosis

    The goal of this observational study to examine the effects of cooling on balance in persons with Multiple Sclerosis. Persons with Multiple Sclerosis frequently have problems with balance leading to falls and related injuries, as well as avoidance of activities that may challenge balance. Persons w…

    Stage

    Not phased

    Ages

    18 to 75

    Site

    Hunter College, Physical Therapy Department, City University of New York, New York, New York

    Run by

    Hunter College of City University of New York

    See if you can join NCT06094855 on ClinicalTrials.gov